A study evaluating drug drug interaction between Uprifosbuvir and dolutegravir, raltegravir, rilpivirine and tenofovir disoproxil fumarate.

Trial Profile

A study evaluating drug drug interaction between Uprifosbuvir and dolutegravir, raltegravir, rilpivirine and tenofovir disoproxil fumarate.

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Sep 2017

At a glance

  • Drugs Uprifosbuvir (Primary) ; Dolutegravir; Raltegravir; Rilpivirine; Tenofovir disoproxil fumarate
  • Indications Hepatitis C
  • Focus Pharmacokinetics
  • Most Recent Events

    • 28 Sep 2017 New trial record
    • 01 Sep 2017 Results published in the Clinical Pharmacology in Drug Development : 2017 Annual Meeting of the American College of Clinical Pharmacology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top